In last trading session, Eterna Therapeutics Inc (NASDAQ:ERNA) saw 0.44 million shares changing hands with its beta currently measuring 4.32. Company’s recent per share price level of $0.32 trading at -$0.01 or -3.03% at ring of the bell on the day assigns it a market valuation of $16.61M. That closing price of ERNA’s stock is at a discount of -718.75% from its 52-week high price of $2.62 and is indicating a premium of 31.25% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 857.68K if we extend that period to 3-months.

Eterna Therapeutics Inc (NASDAQ:ERNA) trade information

Upright in the red during last session for losing -3.03%, in the last five days ERNA remained trading in the green while hitting it’s week-highest on Thursday, 01/02/25 when the stock touched $0.32 price level, adding 18.47% to its value on the day. Eterna Therapeutics Inc’s shares saw a change of 9.97% in year-to-date performance and have moved 9.97% in past 5-day. Eterna Therapeutics Inc (NASDAQ:ERNA) showed a performance of -19.15% in past 30-days. Number of shares sold short was 44458.0 shares which calculate 1.07 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.06% during past 5 years.

Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders

Insiders are in possession of 336.35% of company’s total shares while institution are holding 11.00 percent of that, with stock having share float percentage of -4.65%. Investors also watch the number of corporate investors in a company very closely, which is 11.00% institutions for Eterna Therapeutics Inc that are currently holding shares of the company.